Agios Pharmaceuticals | Kundefordringer



Trade Debtors Endring Dato
AbbVie USD 10.92B 553M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amgen USD 6.78B 535M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
Astellas Pharma JPY 657.6B 86.71B 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Bayer EUR 12.5B 1.33B 2024-12
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Daiichi Sankyo JPY 624.17B 92.34B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Exelixis USD 265.44M 4.27M 2025-01
Gilead Sciences USD 4.42B 167M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
Incyte USD 853.15M 94.7M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
Merck USD 11.12B 1.06B 2024-12
Moderna USD 592M 1.24B 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Agios Pharmaceuticals Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.